Open access
Open access
Powered by Google Translator Translator

M-A: Tocilizumab in COVID-19 – “For hospitalized COVID-19 patients, there is some evidence that tocilizumab use may be associated with a short-term mortality benefit, but further high-quality data are required”.

24 May, 2021 | 08:39h | UTC

Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials – Intensive Care Medicine

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.